Raymed Labs Ltd Stock Price Today (NSE: RAYLA)
Fundamental Score
Raymed Labs Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Raymed Labs Ltd share price today is ₹3.83, up +0.00% on NSE/BSE as of 22 September 2026. Raymed Labs Ltd (RAYLA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹2.08 (Cr). The 52-week high for RAYLA share price is ₹3.83 and the 52-week low is ₹3.65.
Raymed Labs Ltd Share Price Chart — NSE/BSE Historical Performance
Raymed Labs Ltd share price chart: 4.93% return over the past month. 52-week high ₹3.83, 52-week low ₹3.65.
Raymed Labs Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 0.00 (Cr) | |
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | 1.00 (Cr) | |
| ₹3.65 | ₹3.65 | ₹3.65 | ₹3.65 | 0.00 (Cr) |
Raymed Labs Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹3.83 | ₹3.83 | ₹3.83 | ₹3.83 | +0.00% | |
| ₹3.65 | ₹3.83 | ₹3.65 | ₹3.83 | +4.93% | |
| ₹3.65 | ₹3.65 | ₹3.65 | ₹3.65 | +0.00% | |
| ₹3.65 | ₹3.65 | ₹3.65 | ₹3.65 | +0.00% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Raymed Labs Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Raymed Labs Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of RAYLA across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Profit Decline Concern (-442.86%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (-1.69x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Liquidity Concerns (Current Ratio: 0.13)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Negative Free Cash Flow (₹-2.68 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.96%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Raymed Labs Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Raymed Labs Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Raymed Labs LtdRaymed Labs Ltd...Selected✓ RAYLA • 531207 | 0/100 | ₹3.83₹4 | ₹2.08₹2.08 | — — | — — | — — | — — | — — | — — | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Raymed Labs Ltd Quarterly Performance
Latest quarterly metrics for RAYLA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-442.86%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Raymed Labs Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for RAYLA — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Raymed Labs Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Raymed Labs Ltd (RAYLA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Raymed Labs Ltd
About RAYLA (Raymed Labs Ltd)
Raymed Labs Ltd (RAYLA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current m...arket capitalisation of ₹2.08 (Cr). Investors tracking RAYLA share price can monitor key metrics including P/E ratio, promoter holding of 32.27%, and quarterly earnings growth.
Company Details
RAYLA Share Price: Frequently Asked Questions
What is the current share price of Raymed Labs Ltd?
Raymed Labs Ltd (RAYLA) trades at ₹3.83 on NSE and BSE. Market cap ₹2.08 (Cr). Educational data only.
What is the P/E ratio of Raymed Labs Ltd?
Raymed Labs Ltd has a P/E of N/Ax vs industry average 34.89x.
What is the Bull Run score for Raymed Labs Ltd?
Raymed Labs Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Raymed Labs Ltd pay dividends?
Raymed Labs Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Raymed Labs Ltd?
Raymed Labs Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Raymed Labs Ltd?
Raymed Labs Ltd has debt-to-equity of N/A.
Is Raymed Labs Ltd a good investment?
Bull Run gives Raymed Labs Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.